(Q39819588)

14 September 2017

In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents (English)

1 reference

14 September 2017

Gootz T

1

1 reference

14 September 2017

Retsema J

2

1 reference

14 September 2017

Girard A

3

1 reference

14 September 2017

Hamanaka E

4

1 reference

14 September 2017

Anderson M

5

1 reference

14 September 2017

Sokolowski S

6

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

33

1 reference

14 September 2017

8

1 reference

14 September 2017

1160-1166

1 reference

Protein measurement with the Folin phenol reagent

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Thienamycin: development of imipenen-cilastatin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the Future

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Comparative in vitro antibacterial activity of Sch 34343, a novel penem antibiotic

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

In vitro activity and beta-lactamase stability of a new penem, CGP 31608

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Penems: in vitro and in vivo experiments

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

In Vitro Activity of Furazlocillin (Bay k 4999) Compared with Those of Mezlocillin, Piperacillin, and Standard Beta-Lactam Antibiotics

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Properties of the Penicillin-Binding Proteins of Escherichia coli K12

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Resistance to Cefamandole: A Collaborative Study of Emerging Clinical Problems

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

HRE 664, a new parenteral penem. I. Antibacterial activity in vitro.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172617

In-vitro activity of two new carbapenems FCE 22101 and CGP 31608 in comparison with imipenem

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2679370

12 December 2020

inferred from PubMed ID database lookup

Sch 29482--a novel penem antibiotic: an in-vitro comparison of its activity with other beta-lactams

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2679370

12 December 2020

inferred from PubMed ID database lookup

Antibacterial activity of an oral penem, Sch 29482

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/2679370

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.33.8.1160

1 reference

release_dvtda3ouavf6bizzsrw5sbz7pi

14 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dvtda3ouavf6bizzsrw5sbz7pi

24 November 2022

mapped directly with Wikidata item

1 reference

14 September 2017

PubMed publication ID

2679370

1 reference